STOK — Stoke Therapeutics, Inc.
—
Nasdaq ·
Health Care ·
Pharmaceuticals ·
CIK 1623526 ·
Last close
$26.41
Market Cap
$1.73B
52W High
$40.22
52W Low
$22.05
ADV30
1,146,393
Next earnings
2026-10-29
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | Gross profit | Op income | Net income | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Sep 2026 | — | — | — | — | — | — | — |
| Jun 2026 | 9,325,000 | — | -65,429,000 | -61,618,000 | 393,966,000 | 110,004,000 | 48,419,000 |
| Mar 2026 | 6,229,000 | — | -53,418,000 | -50,003,000 | 443,277,000 | 155,659,000 | 48,400,000 |
| Dec 2025 | 1,402,000 | — | -61,439,000 | -57,934,000 | 418,434,000 | 84,220,000 | 65,977,000 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$-210,307,000
Investing CF
$-11,558,000
Financing CF
$248,742,000
CapEx
$-5,412,000
Dividends Paid
—
Buybacks
—
EPS Diluted TTM
$-3.45
As of
2026-11-08
Balance + Analyst (yfinance extras)
Retained Earnings
$-682,980,000
Inventory
—
Receivables
$10,076,000
ST Investments
$211,916,000
EBIT TTM
$-257,601,000
Pretax Income TTM
$-243,199,000
Interest Exp TTM
—
Analysts
13
Yahoo Snapshot (yfinance, live)
Total Revenue
$28,210,000
EBITDA
$-255,844,000
Free Cash Flow
$-125,546,624
Enterprise Value
$1,418,617,344
Total Cash
$319,187,008
Total Debt
$1,922,000
Shares Out
65,406,268
Trailing EPS
$-3.81
Book Value
$5.44
ROE
-73.6%
ROA
-42.0%
Div Yield
0.00%
Annual Trend (SEC EDGAR, last 4y)
Revenues vs Net Income (last 4y)
| FY end | Revenues | Op income | Net income | Assets | Liabilities | Equity | Op cash flow |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 184,420,000 | -20,590,000 | -6,885,000 | 418,434,000 | 65,977,000 | 352,457,000 | 45,585,000 |
| Dec 2024 | 36,555,000 | -101,372,000 | -88,981,000 | 271,555,000 | 42,534,000 | 229,021,000 | -86,851,000 |
| Dec 2023 | 8,780,000 | -114,773,000 | -104,699,000 | 228,342,000 | 68,777,000 | 159,565,000 | -81,067,000 |
| Dec 2022 | 12,405,000 | -104,356,000 | -101,067,000 | 256,067,000 | 71,218,000 | 184,849,000 | -31,866,000 |
TTM Snapshot
Revenues TTM
$27,588,000
NetIncome TTM
$-207,902,000
OpCashFlow TTM
—
Assets (Latest)
$393,966,000
Forward EPS
$-4.09
Max Pain — expiry 2027-02-19 (volume-derived — Yahoo OI feed degraded)
max pain strike: $15.00 · spot: $26.69 · call volume: 26 · put volume: 7
Expected Move to 2027-02-19:
±$6.60
(24.73%) —
implied range
$20.09 –
$33.29
· ATM straddle on $25.00 strike
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| RARE | Ultragenyx Pharmaceutical Inc. | $1.70B | $16.70 | — |
| SUPN | Supernus, Inc. | $1.69B | $29.04 | — |
| BRVE | Braveheart Bio, Inc. | $1.69B | $18.78 | — |
| SDGR | Schrodinger, Inc. | $1.68B | $25.66 | — |
| ZYME | Zymeworks Inc. | $1.78B | $25.84 | — |
News headlines (Yahoo Finance, 1h cache)
Stoke Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
2026-11-17 21:01 · Yahoo
Stoke Therapeutics (STOK) Faces A Valuation Test Following Weaker Nine Month Results
2026-11-07 04:26 · Yahoo
Stoke Therapeutics to Present at Upcoming Investor Conferences in November
2026-11-03 13:00 · Yahoo
Stoke Therapeutics (STOK) Stock Price Faces Q3 Results Cash Burn Question
2026-10-31 22:11 · Yahoo
Stoke Therapeutics, Inc. Q3 2026 Earnings Call Summary
2026-10-30 12:30 · Yahoo
Stoke Therapeutics, Inc. (STOK) Reports Q3 Loss, Tops Revenue Estimates
2026-10-29 22:05 · Yahoo
Stoke Therapeutics Announces Third Quarter 2026 Financial Results and Provides Business Updates
2026-10-29 20:01 · Yahoo
Stoke Therapeutics to Host Webcast and Conference Call to Discuss Third Quarter 2026 Business and Financial Updates
2026-10-22 12:00 · Yahoo
Stoke Therapeutics Presents Data Supporting the Disease-Modifying Potential of STK-002 in Autosomal Dominant Optic Atrophy (ADOA) at the American Academy of Ophthalmology (AAO) 2026 Annual Meeting
2026-10-12 12:00 · Yahoo
FDA Alignment on Zorevunersen Endpoints Could Be A Game Changer For Stoke Therapeutics (STOK)
2026-10-09 23:09 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.